OPALIN
gene geneOn this page
Also known as TMP10HTMP10
Summary
OPALIN (oligodendrocytic myelin paranodal and inner loop protein, HGNC:20707) is a protein-coding gene on chromosome 10q24.1, encoding Opalin (Q96PE5). Central nervous system-specific myelin protein that increase myelin genes expression during oligodendrocyte differentiation.
Predicted to be involved in regulation of oligodendrocyte differentiation. Located in Golgi apparatus.
Source: NCBI Gene 93377 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 35 total
- MANE Select transcript:
NM_033207
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20707 |
| Approved symbol | OPALIN |
| Name | oligodendrocytic myelin paranodal and inner loop protein |
| Location | 10q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TMP10, HTMP10 |
| Ensembl gene | ENSG00000197430 |
| Ensembl biotype | protein_coding |
| OMIM | 617200 |
| Entrez | 93377 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 protein_coding
ENST00000371172, ENST00000393870, ENST00000393871, ENST00000419479, ENST00000536387, ENST00000611913, ENST00000897676, ENST00000897677, ENST00000963709
RefSeq mRNA: 10 — MANE Select: NM_033207
NM_001040102, NM_001040103, NM_001284320, NM_001284321, NM_001284322, NM_001284323, NM_001284324, NM_001284326, NM_001284327, NM_033207
CCDS: CCDS41556, CCDS44466, CCDS60602, CCDS73172, CCDS73173, CCDS7448
Canonical transcript exons
ENST00000371172 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000987314 | 96348289 | 96348345 |
| ENSE00001454537 | 96343221 | 96346117 |
| ENSE00001932034 | 96358894 | 96359002 |
| ENSE00003655237 | 96355255 | 96355290 |
| ENSE00003729087 | 96349707 | 96349826 |
| ENSE00003735898 | 96351378 | 96351410 |
Expression profiles
Bgee: expression breadth broad, 78 present calls, max score 97.00.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 7.0912 / max 904.2777, expressed in 90 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 110861 | 3.7015 | 87 |
| 110859 | 1.2474 | 78 |
| 110862 | 0.8068 | 78 |
| 110860 | 0.6612 | 74 |
| 110858 | 0.5738 | 71 |
| 110864 | 0.0354 | 25 |
| 110863 | 0.0341 | 23 |
| 110856 | 0.0311 | 23 |
Top tissues by expression
227 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lateral globus pallidus | UBERON:0002476 | 97.00 | gold quality |
| corpus callosum | UBERON:0002336 | 96.92 | gold quality |
| putamen | UBERON:0001874 | 96.89 | gold quality |
| amygdala | UBERON:0001876 | 95.61 | gold quality |
| caudate nucleus | UBERON:0001873 | 94.81 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 94.29 | gold quality |
| Ammon’s horn | UBERON:0001954 | 93.51 | gold quality |
| substantia nigra | UBERON:0002038 | 93.45 | gold quality |
| globus pallidus | UBERON:0001875 | 93.14 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 92.67 | gold quality |
| spinal cord | UBERON:0002240 | 92.60 | gold quality |
| medial globus pallidus | UBERON:0002477 | 92.53 | gold quality |
| midbrain | UBERON:0001891 | 92.45 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.28 | gold quality |
| hypothalamus | UBERON:0001898 | 91.40 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 90.57 | gold quality |
| right frontal lobe | UBERON:0002810 | 90.43 | gold quality |
| prefrontal cortex | UBERON:0000451 | 90.28 | gold quality |
| temporal lobe | UBERON:0001871 | 89.93 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 89.78 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 88.83 | gold quality |
| frontal cortex | UBERON:0001870 | 88.80 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 88.49 | gold quality |
| postcentral gyrus | UBERON:0002581 | 87.64 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 87.57 | gold quality |
| cerebral cortex | UBERON:0000956 | 87.11 | gold quality |
| parietal lobe | UBERON:0001872 | 86.81 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 86.68 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 86.50 | gold quality |
| neocortex | UBERON:0001950 | 86.43 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-84465 | yes | 12.31 |
| E-ANND-3 | yes | 4.93 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CREB1, MYT1, SMO
miRNA regulators (miRDB)
78 targeting OPALIN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-548AI | 99.69 | 69.24 | 1494 |
| HSA-MIR-548BA | 99.69 | 69.14 | 1514 |
| HSA-MIR-570-5P | 99.69 | 69.24 | 1494 |
| HSA-MIR-6887-3P | 99.66 | 67.83 | 1778 |
Literature-anchored findings (GeneRIF, showing 2)
- highly sialylglycosylated Opalin has a role in an intermembranous function of the myelin paranodal loops in the central nervous system (PMID:18490449)
- TMEM10 Promotes Oligodendrocyte Differentiation and is Expressed by Oligodendrocytes in Human Remyelinating Multiple Sclerosis Plaques. (PMID:30837646)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Opalin | ENSMUSG00000050121 |
| rattus_norvegicus | Opalin | ENSRNOG00000022386 |
Protein
Protein identifiers
Opalin — Q96PE5 (reviewed: Q96PE5)
Alternative names: Oligodendrocytic myelin paranodal and inner loop protein, Transmembrane protein 10
All UniProt accessions (3): Q96PE5, A0A0A0MS47, A0A0A0MTN4
UniProt curated annotations — full annotation on UniProt →
Function. Central nervous system-specific myelin protein that increase myelin genes expression during oligodendrocyte differentiation. Promotes oligodendrocyte terminal differentiation.
Subcellular location. Cell membrane.
Tissue specificity. Brain specific; expressed in oligodendrocytes. Expressed in oligodendrocytes in remyelinating multiple sclerosis plaques.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96PE5-1 | 1 | yes |
| Q96PE5-2 | 2 | |
| Q96PE5-3 | 3 | |
| Q96PE5-4 | 4 |
RefSeq proteins (10): NP_001035191, NP_001035192, NP_001271249, NP_001271250, NP_001271251, NP_001271252, NP_001271253, NP_001271255, NP_001271256, NP_149984* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026609 | Opalin | Family |
UniProt features (13 total): splice variant 3, glycosylation site 3, topological domain 2, region of interest 2, chain 1, transmembrane region 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96PE5-F1 | 62.88 | 0.09 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (3): 6, 12, 14
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 49 (showing top):
GOBP_NEUROGENESIS, GOBP_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION, GOBP_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION, DBP_Q6, GOBP_GLIAL_CELL_DIFFERENTIATION, GOCC_CELL_CELL_JUNCTION, GOBP_OLIGODENDROCYTE_DIFFERENTIATION, GOCC_CELL_CELL_CONTACT_ZONE, LEIN_OLIGODENDROCYTE_MARKERS, LEIN_MIDBRAIN_MARKERS, GOCC_ANCHORING_JUNCTION, PEDRIOLI_MIR31_TARGETS_UP, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ZNF768_TARGET_GENES, MIR3646
GO Biological Process (1): regulation of oligodendrocyte differentiation (GO:0048713)
GO Molecular Function (0):
GO Cellular Component (4): Golgi apparatus (GO:0005794), plasma membrane (GO:0005886), cell-cell contact zone (GO:0044291), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of glial cell differentiation | 1 |
| oligodendrocyte differentiation | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cell-cell junction | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1526 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OPALIN | TMEM70 | Q9BUB7 | 952 |
| OPALIN | ERMN | Q8TAM6 | 690 |
| OPALIN | PLLP | Q9Y342 | 674 |
| OPALIN | MOBP | Q13875 | 634 |
| OPALIN | PLP1 | P04400 | 598 |
| OPALIN | ENPP6 | Q6UWR7 | 520 |
| OPALIN | KLK6 | Q92876 | 507 |
| OPALIN | SEPTIN4 | O43236 | 476 |
| OPALIN | MBP | P02686 | 446 |
| OPALIN | OLIG2 | Q13516 | 425 |
| OPALIN | GPR17 | Q13304 | 423 |
| OPALIN | OLIG1 | Q8TAK6 | 423 |
| OPALIN | MAG | P20916 | 422 |
| OPALIN | EGR2 | P11161 | 421 |
| OPALIN | GADL1 | Q6ZQY3 | 421 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OPALIN | BTAF1 | psi-mi:“MI:0914”(association) | 0.530 |
| TRPV2 | OPALIN | psi-mi:“MI:0915”(physical association) | 0.370 |
| OPALIN | GPR89A | psi-mi:“MI:0914”(association) | 0.350 |
| OPALIN | FAM171A2 | psi-mi:“MI:0914”(association) | 0.350 |
| GMFB | RIPK2 | psi-mi:“MI:0914”(association) | 0.350 |
| HBB | HNRNPH2 | psi-mi:“MI:0914”(association) | 0.350 |
| IL1RN | PSMG1 | psi-mi:“MI:0914”(association) | 0.350 |
| EPHA4 | OPALIN | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (210): OPALIN (Synthetic Lethality), TUBGCP4 (Affinity Capture-MS), MDN1 (Affinity Capture-MS), GHITM (Affinity Capture-MS), IPO8 (Affinity Capture-MS), LGALS3 (Affinity Capture-MS), RNF213 (Affinity Capture-MS), MON2 (Affinity Capture-MS), PDS5B (Affinity Capture-MS), TMEM55B (Affinity Capture-MS), ATP2A1 (Affinity Capture-MS), BTAF1 (Affinity Capture-MS), CD97 (Affinity Capture-MS), RTTN (Affinity Capture-MS), TUBB8 (Affinity Capture-MS)
ESM2 similar proteins: A0A0B4K753, A0A3G1DJJ7, A8P353, B0DX25, B2RWJ3, F5HAM4, F5HCK7, F5HGQ8, O39830, O59776, P06481, P06498, P06849, P09266, P09707, P0C5T6, P0C9Y9, P10407, P10471, P11313, P11625, P17523, P17524, P28979, P32845, P34890, P40688, P69338, P69339, P79943, Q0A2G4, Q32LJ5, Q4JQX4, Q5SV17, Q5T7R7, Q66125, Q66262, Q6DPQ1, Q6DPT7, Q6DPU1
Diamond homologs: Q29102, Q5E9I3, Q5R461, Q7M750, Q96PE5
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SMO | “up-regulates quantity” | OPALIN | “transcriptional regulation” |
| OPALIN | up-regulates | Myelination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
665 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:96345990:T:A | donor_gain | 0.9900 |
| 10:96346119:T:C | acceptor_gain | 0.9900 |
| 10:96348283:TCTTA:T | donor_loss | 0.9900 |
| 10:96348284:CTTA:C | donor_loss | 0.9900 |
| 10:96348285:TTA:T | donor_loss | 0.9900 |
| 10:96348286:TAC:T | donor_loss | 0.9900 |
| 10:96348287:A:AC | donor_gain | 0.9900 |
| 10:96348288:C:CC | donor_gain | 0.9900 |
| 10:96348288:CCT:C | donor_gain | 0.9900 |
| 10:96348341:CTTTC:C | acceptor_gain | 0.9900 |
| 10:96348344:TCCTA:T | acceptor_loss | 0.9900 |
| 10:96348345:CCTAA:C | acceptor_loss | 0.9900 |
| 10:96348347:T:C | acceptor_loss | 0.9900 |
| 10:96348351:T:TC | acceptor_gain | 0.9900 |
| 10:96348360:A:AC | acceptor_gain | 0.9900 |
| 10:96348360:A:C | acceptor_gain | 0.9900 |
| 10:96349708:T:TA | donor_gain | 0.9900 |
| 10:96348342:TTTC:T | acceptor_gain | 0.9800 |
| 10:96348343:TTC:T | acceptor_gain | 0.9800 |
| 10:96348346:C:CC | acceptor_gain | 0.9800 |
| 10:96348351:T:C | acceptor_gain | 0.9800 |
| 10:96348362:A:C | acceptor_gain | 0.9800 |
| 10:96349702:ATCAC:A | donor_loss | 0.9700 |
| 10:96349703:TCA:T | donor_loss | 0.9700 |
| 10:96349704:CA:C | donor_loss | 0.9700 |
| 10:96349705:AC:A | donor_loss | 0.9700 |
| 10:96349822:CAGTC:C | acceptor_gain | 0.9700 |
| 10:96348344:TC:T | acceptor_gain | 0.9600 |
| 10:96348345:CC:C | acceptor_gain | 0.9600 |
| 10:96349833:C:CT | acceptor_gain | 0.9600 |
AlphaMissense
907 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:96345970:A:G | W133R | 0.944 |
| 10:96345970:A:T | W133R | 0.944 |
| 10:96345968:C:A | W133C | 0.930 |
| 10:96345968:C:G | W133C | 0.930 |
| 10:96345950:G:C | S139R | 0.911 |
| 10:96345950:G:T | S139R | 0.911 |
| 10:96345952:T:G | S139R | 0.911 |
| 10:96349792:A:T | I36K | 0.902 |
| 10:96349789:G:C | P37R | 0.893 |
| 10:96349792:A:C | I36R | 0.882 |
| 10:96349777:G:T | A41D | 0.880 |
| 10:96349771:G:T | A43D | 0.873 |
| 10:96345960:G:T | P136H | 0.869 |
| 10:96345966:A:G | L134P | 0.867 |
| 10:96345971:C:A | W132C | 0.860 |
| 10:96345971:C:G | W132C | 0.860 |
| 10:96349789:G:T | P37Q | 0.860 |
| 10:96345966:A:T | L134H | 0.857 |
| 10:96355285:A:C | F3L | 0.853 |
| 10:96355285:A:T | F3L | 0.853 |
| 10:96355287:A:G | F3L | 0.853 |
| 10:96345961:G:T | P136T | 0.848 |
| 10:96345960:G:A | P136L | 0.845 |
| 10:96345975:A:G | L131S | 0.836 |
| 10:96346059:A:T | I103K | 0.830 |
| 10:96345945:T:A | E141V | 0.817 |
| 10:96349768:A:C | L44R | 0.816 |
| 10:96349796:C:G | G35R | 0.813 |
| 10:96349798:G:T | A34E | 0.810 |
| 10:96355273:G:C | F7L | 0.806 |
dbSNP variants (sampled 300 via entrez): RS1000121271 (10:96353164 C>A), RS1000175447 (10:96353546 G>A), RS1000300067 (10:96359472 C>A), RS1000401931 (10:96359791 G>A), RS1000447957 (10:96347584 C>T), RS1000551738 (10:96352444 C>G), RS1000690306 (10:96360013 T>G), RS1000996441 (10:96348731 G>C), RS1001019048 (10:96346773 A>C,G), RS1001047336 (10:96349131 A>G), RS1001194293 (10:96358685 G>C), RS1001214875 (10:96347545 C>T), RS1001791745 (10:96351873 A>G), RS1001844806 (10:96357866 A>G), RS1002070164 (10:96345562 C>T)
Disease associations
OMIM: gene MIM:617200 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009297_2 | BMI at 3 years old | 1.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol F | increases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| butyraldehyde | increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.